Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.27 CAD -1.82% Market Closed
Market Cap: 66.9m CAD

Wall Street
Price Targets

TLT Price Targets Summary
Theralase Technologies Inc

Wall Street analysts forecast TLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLT is 0.71 CAD with a low forecast of 0.71 CAD and a high forecast of 0.74 CAD.

Lowest
Price Target
0.71 CAD
162% Upside
Average
Price Target
0.71 CAD
164% Upside
Highest
Price Target
0.74 CAD
172% Upside
Theralase Technologies Inc Competitors:
Price Targets
300633
SonoScape Medical Corp
33% Upside
HYPR
Hyperfine Inc
40% Upside
853
Microport Scientific Corp
28% Upside
6960
Fukuda Denshi Co Ltd
17% Downside
SENS
Senseonics Holdings Inc
149% Upside
BBNX
Beta Bionics Inc
80% Upside
SRTS
Sensus Healthcare Inc
41% Upside
301367
BMC Medical Co Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Theralase Technologies Inc

For the last 13 years the compound annual growth rate for Theralase Technologies Inc's revenue is -5%. The projected CAGR for the next 3 years is 227%.

-5%
Past Growth
227%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Theralase Technologies Inc

Operating Income forecast
is not available for
Theralase Technologies Inc

Net Income
Forecast

Net Income Estimate
Theralase Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLT's stock price target?
Price Target
0.71 CAD

According to Wall Street analysts, the average 1-year price target for TLT is 0.71 CAD with a low forecast of 0.71 CAD and a high forecast of 0.74 CAD.

What is Theralase Technologies Inc's Revenue forecast?
Projected CAGR
227%

For the last 13 years the compound annual growth rate for Theralase Technologies Inc's revenue is -5%. The projected CAGR for the next 3 years is 227%.

Back to Top